4
Changes in Ownership
Arbutus Biopharma Corp Filed Acc 0001567619-18-004380
Options or other derivatives
- Director acquired 44,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
POTTER MYRTLE S · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-10-18 | Grant or award : show line 1 in the form Director Share Option (Right to Buy) | +44,000 | 44,000 | D |
Loading xslF345X03/doc1.xml…